Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 3, 2005

View Archived Issues

CPU-86017 enhances BBB permeability as a result of oxidative stress

Depomed and Esprit Pharma enter Proquin XR marketing agreement

MRX-3 improves asthma symptoms in animal studies

First stage of phase II MetXia study completed

Aegis signs new deal for Intravail technology

Phogen and Cancer Research Technology sign agreement for VP22 technology

Harvard and Crucell receive NIH grant for next-generation AdVac vaccines for HIV/AIDS

CE Mark approval for Endeavor drug-eluting stent

WX-671 successfully completes first phase I study

Indevus inlicenses Nebido U.S. rights

Curcumin demonstrates antidepressant-like effects

HX-531 pretreatment improves responses to leptin

In vitro data presented on novel VCAM-1 inhibitor from Novartis

Novel inhibitors of anthrax lethal factor demonstrate significant protection in vivo

Procaine protects against beta-amyloid neurotoxicity in vitro

Orphan drug designation for Large Scale Biology's lysosomal acid lipase

Celebrex approved for ankylosing spondylitis

Japanese approval for Cleactor for acute pulmonary embolism

Final phase I data on the effects and safety of Proellex in uterine fibroids

Therapeutic agents for respiratory and inflammatory disorders in early development

Sevelamer decreases mortality and morbidity of hemodialysis patients

CR-665 shows a promising safety and pharmacokinetic profile in healthy subjects

Novel agents disclosed for the treatment of diabetes and related disorders

Dompe patent claims novel chemokine CXCR1/CXCR2 receptor antagonists

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...